Dietary and socio-economic factors in relation to Helicobacter pylori re-infection

World Journal of Gastroenterology

Volumn 15, Issue 9, 2009, Pages 1119-1125

  Jarosz, Mirosław ^a   Rychlik, Ewa ^a   Siuba, Hagdalena ^a   Respondek, Wioleta ^a   Ryzko Skiba, Małgorzata ^a   Sajór, Iwona ^a   Gugała, Sylwia ^a   Błazejczyk, Tomasz ^a   Ciok, Janusz ^a  

^a NATIONAL FOOD AND NUTRITION INSTITUTE   (Poland)

Author keywords

Helicobacter pylori re infection; Lifestyle factors; Nutrition; Probiotics; Vitamin C

Indexed keywords

ASCORBIC ACID; PROBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DAIRY PRODUCT; DIETARY INTAKE; DISEASE ASSOCIATION; EATING HABIT; EMOTIONAL STRESS; FEMALE; FOOD COMPOSITION; FOOD INTAKE; FRUIT; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; JOB PERFORMANCE; LACTOBACILLUS; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; REINFECTION; RISK REDUCTION; SOCIOECONOMICS; VEGETABLE; DIET; MIDDLE AGED; PATHOPHYSIOLOGY; POLAND; RECURRENT DISEASE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DAIRY PRODUCTS; DIET; FEMALE; FRUIT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; POLAND; PROBIOTICS; RECURRENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; VEGETABLES; YOUNG ADULT;

EID: 65549115591     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1119     Document Type: Article

References (53)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-S128
2. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301
3. Feldman RA, Eccersley AJ, Hardie JM. Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio. Br Med Bull 1998; 54: 39-53
4. Salgueiro J, Zubillaga M, Goldman C, Barrado A, Martinez Sarrasague M, Leonardi N, Boccio J. Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection? Aliment Pharmacol Ther 2004; 20: 1029-1034
5. Matysiak-Budnik T, Mégraud F. Epidemiology of Helicobacter pylori infection with special reference to professional risk. J Physiol Pharmacol 1997; 48 Suppl 4: 3-17
6. Bak-Romaniszyn L, Małecka-Panas E, Zeman K, Czkwianianc E, Kozłowski W, Kulig A, Kałuzyński A, Suski S. Helicobacter pylori infection in the etiopathogenesis of duodenal ulcer in children. J Physiol Pharmacol 1996; 47: 209-220
7. Ernst PB, Gold BD. Helicobacter pylori in childhood: new insights into the immunopathogenesis of gastric disease and implications for managing infection in children. J Pediatr Gastroenterol Nutr 1999; 28: 462-473
8. Przybyszewska K, Bielanski W, Fyderek K. Frequency of Helicobacter pylori infection in children under 4 years of age. J Physiol Pharmacol 2006; 57 Suppl 3: 113-122
9. Matysiak-Budnik T, Knapik Z, Mégraud F, Lubczynska-Kowalska W, Gosciniak G, Bouchard S, Przondo-Mordarska A, Poniewierka E, Helemejko M, Klempous J. Helicobacter pylori infection in Eastern Europe: seroprevalence in the Polish population of Lower Silesia. Am J Gastroenterol 1996; 91: 2513-2515
10. Czkwianianc E, Bak-Romaniszyn L, Małecka-Panas E, Suski S, Woch G. Prevalence of Helicobacter pylori in children dependently on age and living conditions. J Physiol Pharmacol 1996; 47: 203-207
11. Bures J, Kopácová M, Koupil I, Vorísek V, Rejchrt S, Beránek M, Seifert B, Pozler O, Zivný P, Douda T, Kolesárová M, Pintér M, Palicka V, Holcík J. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006; 11: 56-65
12. Celiński K, Kurzeja-Mirosław A, Słomka M, Cichoz-Lach H, Madro A, Kasztelan-Szczerbińska B. The effects of environmental factors on the prevalence of Helicobacter pylori infection in inhabitants of Lublin Province. Ann Agric Environ Med 2006; 13: 185-191
13. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Ziemlanski S, Reed PI. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998; 7: 449-454
14. Beevers DG, Lip GY, Blann AD. Salt intake and Helicobacter pylori infection. J Hypertens 2004; 22: 1475-1477
15. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthésy-Theulaz I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60: 203-209
16. Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 1998; 64: 4573-4580
17. Pinchuk IV, Bressollier P, Verneuil B, Fenet B, Sorokulova IB, Mégraud F, Urdaci MC. In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother 2001; 45: 3156-3161
18. van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2008; 22: 209-224
19. Ng EK, Lam YH, Sung JJ, Yung MY, To KF, Chan AC, Lee DW, Law BK, Lau JY, Ling TK, Lau WY, Chung SC. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg 2000; 231: 153-158
20. Abu-Mahfouz MZ, Prasad VM, Santogade P, Cutler AF. Helicobacter pylori recurrence after successful eradication: 5-year follow-up in the United States. Am J Gastroenterol 1997; 92: 2025-2028
21. Adachi M, Mizuno M, Yokota K, Miyoshi M, Nagahara Y, Maga T, Ishiki K, Inaba T, Okada H, Oguma K, Tsuji T. Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J Gastroenterol Hepatol 2002; 17: 27-31
22. Ahmad MM, Ahmed DS, Rowshon AH, Dhar SC, Rahman M, Hasan M, Beglinger C, Gyr N, Khan AK. Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults. Digestion 2007; 75: 173-176
23. Kim N, Lim SH, Lee KH, Jung HC, Song IS, Kim CY. Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol 1998; 27: 321-326
24. Gómez Rodríguez BJ, Rojas Feria M, García Montes MJ, Romero Castro R, Hergueta Delgado P, Pellicer Bautista FJ, Herrerías Gutiérrez JM. Incidence and factors influencing on Helicobacter pylori infection recurrence. Rev Esp Enferm Dig 2004; 96: 620-623; 424-427
25. Matysiak-Budnik T, Mégraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer 2006; 42: 708-716
26. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781
27. Dzieniszewski J, Jarosz M. Guidelines in the medical treatment of Helicobacter pylori infection. J Physiol Pharmacol 2006; 57 Suppl 3: 143-154
28. Aydin A, Ersöz G, Ozütemiz O, Tunçyürek M. Low reinfection rate of Helicobacter pylori infection in Turkey. J Clin Gastroenterol 2000; 30: 337
29. Shi R, Xu S, Zhang H, Ding Y, Sun G, Huang X, Chen X, Li X, Yan Z, Zhang G. Prevalence and risk factors for Helicobacter pylori infection in Chinese populations. Helicobacter 2008; 13: 157-165
30. Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93: 2097-2101
31. Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004; 70: 518-526
32. Johnson-Henry KC, Mitchell DJ, Avitzur Y, Galindo-Mata E, Jones NL, Sherman PM. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci 2004; 49: 1095-1102
33. Ushiyama A, Tanaka K, Aiba Y, Shiba T, Takagi A, Mine T, Koga Y. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J Gastroenterol Hepatol 2003; 18: 986-991
34. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41: 49-55
35. Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007; 137: 812S-818S
36. Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D, Gigante G, Gasbarrini G, Gasbarrini A. Role of probiotics in patients with Helicobacter pylori infection. Helicobacter 2007; 12 Suppl 2: 59-63
37. Wendakoon CN, Thomson AB, Ozimek L. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 2002; 65: 16-20
38. Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000; 14: 1625-1629
39. Sýkora J, Valecková K, Amlerová J, Siala K, Dedek P, Watkins S, Varvarovská J, Stozický F, Pazdiora P, Schwarz J. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692-698
40. Park SK, Park DI, Choi JS, Kang MS, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI. The effect of probiotics on Helicobacter pylori eradication. Hepatogastroenterology 2007; 54: 2032-2036
41. de Bortoli N, Leonardi G, Ciancia E, Merlo A, Bellini M, Costa F, Mumolo MG, Ricchiuti A, Cristiani F, Santi S, Rossi M, Marchi S. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 2007; 102: 951-956
42. Plewińska E, Płaneta-Małecka I, Bak-Romaniszyn L, Czkwianianc E, Małecka-Panas E. Probiotics in the treatment of Helicobacter pylori infection in children. Gastroenterol Pol 2006; 13: 315-319
43. Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Maurogiovanni G, Bucci N, De Canio A, Indrio F, Cavallo L, Ierardi E, Miniello VL. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 2008; 13: 127-134
44. Goldman CG, Barrado DA, Balcarce N, Rua EC, Oshiro M, Calcagno ML, Janjetic M, Fuda J, Weill R, Salgueiro MJ, Valencia ME, Zubillaga MB, Boccio JR. Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 2006; 22: 984-988
45. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007; 25: 155-168
46. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M. Recommendations for probiotic use. J Clin Gastroenterol 2006; 40: 275-278
47. Shi LQ, Zheng RL. DNA damage and oxidative stress induced by Helicobacter pylori in gastric epithelial cells: protection by vitamin C and sodium selenite. Pharmazie 2006; 61: 631-637
48. Ruiz B, Rood JC, Fontham ET, Malcom GT, Hunter FM, Sobhan M, Johnson WD, Correa P. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994; 89: 533-539
49. Simon JA, Hudes ES, Perez-Perez GI. Relation of serum ascorbic acid to Helicobacter pylori serology in US adults: the Third National Health and Nutrition Examination Survey. J Am Coll Nutr 2003; 22: 283-289
50. Park JH, Kim SY, Kim DW, Lee WG, Rhee KH, Youn HS. Correlation between Helicobacter pylori infection and vitamin C levels in whole blood, plasma, and gastric juice, and the pH of gastric juice in Korean children. J Pediatr Gastroenterol Nutr 2003; 37: 53-62
51. Camargo MC, Piazuelo MB, Mera RM, Fontham ET, Delgado AG, Yepez MC, Ceron C, Bravo LE, Bravo JC, Correa P. Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia. Acta Gastroenterol Latinoam 2007; 37: 238-245
52. Yucel T, Aygin D, Sen S, Yucel O. The prevalence of Helicobacter pylori and related factors among university students in Turkey. Jpn J Infect Dis 2008; 61: 179-183
53. Reshetnikov OV, Denisova DV, Zavyalova LG, Häivä VM, Granberg C. Helicobacter pylori seropositivity among adolescents in Novosibirsk, Russia: prevalence and associated factors. J Pediatr Gastroenterol Nutr 2003; 36: 72-76